7:00 8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:00
Thursday, September 29, 2005
10:15 - 12:15
C-29-06  Photodynamic Therapy and Combination Strategies

Schmidt-Erfurth U. (Wien)

Augustin A. J. (Karlsruhe)
Larsen M. (Herlev)
Leys A. (Leuven)

Registration fee: 150 € / 200 €
No. of Participants: min. 20 / max. 80
Venue: Hall 9


Room Change: Now in Hall 9!

Photodynamic therapy is a widely established treatment modality approved for the treatment of neovascular age-related macular degeneration (AMD). Multiple studies have allowed to identify the patient characteristics which will benefit from verteporfin therapy. Ample experience with combination of verteporfin monotherapy with pharmacological adjuncts such as steroids has significantly improved the prognosis and efficacy of the treatment. Intravitreal administration of triamcinolon has increased the rate of patients with stabilization of vision as well as visual improvement following treatment while reducing the need for retreatments. Established and novel indications for treatment will be presented by experts in the field with a particular emphasis on discussion of rationale and procedures within the instructor panel as well as with the audiance. International guidelines for mono- and combination approaches are presented and illustrated with respect to practical skills and tips.